A citation-based method for searching scientific literature

Jai N Patel, Maxine K Mueller, William J Guffey, Joseph Stegman. J Dev Behav Pediatr 2020
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Understanding the state of pharmacogenomic testing for thiopurine methyltransferase within a large health system.
Adam Root, Randall Johnson, Ann McGee, Hui-Jie Lee, Siyun Yang, Deepak Voora. Pharmacogenomics 2020
2
50

Implementing pharmacogenetic testing in rural primary care practices: a pilot feasibility study.
Lynn G Dressler, Gillian C Bell, Pearl M Abernathy, Karl Ruch, Sheri Denslow. Pharmacogenomics 2019
5
50

Effect of CYP3A4, CYP3A5, and ABCB1 Polymorphisms on Intravenous Tacrolimus Exposure and Adverse Events in Adult Allogeneic Stem Cell Transplant Patients.
Issam S Hamadeh, Qing Zhang, Nury Steuerwald, Alicia Hamilton, Lawrence J Druhan, Meredith McSwain, Yordanis Diez, Stephanie Rusin, Yimei Han, James Symanowski,[...]. Biol Blood Marrow Transplant 2019
12
50

Pain Management Using Clinical Pharmacy Assessments With and Without Pharmacogenomics in an Oncology Palliative Medicine Clinic.
Jai N Patel, Danielle Boselli, Issam S Hamadeh, James Symanowski, Rebecca Edwards, Beth Susi, Rebecca Greiner, Donna Baldassare, Melissa Waller, Stephanie Wodarski,[...]. JCO Oncol Pract 2020
7
50

Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.
Mary V Relling, Matthias Schwab, Michelle Whirl-Carrillo, Guilherme Suarez-Kurtz, Ching-Hon Pui, Charles M Stein, Ann M Moyer, William E Evans, Teri E Klein, Federico Guillermo Antillon-Klussmann,[...]. Clin Pharmacol Ther 2019
176
50

Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting.
Susanne B Haga, Jivan Moaddeb, Rachel Mills, Deepak Voora. Pharmacogenomics 2017
10
50

Implementing a personalized medicine cancer program in a community cancer system.
Lynn G Dressler, Gillian C Bell, David P Schuetze, Mark R Steciuk, Oliver A Binns, Rachel E Raab, Pearl M Abernathy, Carolyn M Wilson, Sedope E Kunutsor, Marika C Loveless,[...]. Per Med 2019
4
50

Challenges and Solutions for Future Pharmacy Practice in the Era of Precision Medicine.
Olivia M Dong, Rachel M Howard, Rachel Church, Mackenzie Cottrell, Alan Forrest, Federico Innocenti, Merrie Mosedale, Angela Kashuba, Daniel Gonzalez, Tim Wiltshire. Am J Pharm Educ 2018
2
50

Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update.
M A Martin, J M Hoffman, R R Freimuth, T E Klein, B J Dong, M Pirmohamed, J K Hicks, M R Wilkinson, D W Haas, D L Kroetz. Clin Pharmacol Ther 2014
74
50

Implementing Clinical Pharmacogenomics in the Classroom: Student Pharmacist Impressions of an Educational Intervention Including Personal Genotyping.
Amber Frick, Cristina Benton, Oscar Suzuki, Olivia Dong, Rachel Howard, Hijrah El-Sabae, Tim Wiltshire. Pharmacy (Basel) 2018
9
50

Characterizing the pharmacogenome using molecular inversion probes for targeted next-generation sequencing.
Oscar Suzuki, Olivia M Dong, Rachel M Howard, Tim Wiltshire. Pharmacogenomics 2019
5
50

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.
K R Crews, A Gaedigk, H M Dunnenberger, J S Leeder, T E Klein, K E Caudle, C E Haidar, D D Shen, J T Callaghan, S Sadhasivam,[...]. Clin Pharmacol Ther 2014
382
50

Evaluation of CYP2C19 Genotype-Guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell Transplant.
Jai N Patel, Issam S Hamadeh, Myra Robinson, Zainab Shahid, James Symanowski, Nury Steuerwald, Alicia Hamilton, Emily S Reese, Dragos C Plesca, Justin Arnall,[...]. Clin Pharmacol Ther 2020
13
50

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
J K Hicks, J R Bishop, K Sangkuhl, D J Müller, Y Ji, S G Leckband, J S Leeder, R L Graham, D L Chiulli, A LLerena,[...]. Clin Pharmacol Ther 2015
427
50

Effects of Delivering SLCO1B1 Pharmacogenetic Information in Randomized Trial and Observational Settings.
Bruce Peyser, Emily P Perry, Kavisha Singh, Rosalynn D Gill, Michael R Mehan, Susanne B Haga, Michael D Musty, Nicholas A Milazzo, Dillon Savard, Yi-Ju Li,[...]. Circ Genom Precis Med 2018
22
50

PARC report: health outcomes and value of personalized medicine interventions: impact on patient care.
Christina Mitropoulou, Veronika Litinski, Boyko Kabakchiev, Sara Rogers, George P Patrinos. Pharmacogenomics 2020
4
50

Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing.
S L Van Driest, Y Shi, E A Bowton, J S Schildcrout, J F Peterson, J Pulley, J C Denny, D M Roden. Clin Pharmacol Ther 2014
169
50

Results of the CYP-GUIDES randomized controlled trial: Total cohort and primary endpoints.
Gualberto Ruaño, Saskia Robinson, Theodore Holford, Raveen Mehendru, Seth Baker, Joseph Tortora, John W Goethe. Contemp Clin Trials 2020
4
50

Prescription medication changes following direct-to-consumer personal genomic testing: findings from the Impact of Personal Genomics (PGen) Study.
Deanna Alexis Carere, Tyler J VanderWeele, Jason L Vassy, Cathelijne H van der Wouden, J Scott Roberts, Peter Kraft, Robert C Green. Genet Med 2017
19
50

Pharmacogenomics in the UK National Health Service: opportunities and challenges.
Richard M Turner, William G Newman, Elvira Bramon, Christine J McNamee, Wai Lup Wong, Siraj Misbah, Sue Hill, Mark Caulfield, Munir Pirmohamed. Pharmacogenomics 2020
4
50

Pharmacogenetic testing in psychiatric inpatients with polypharmacy is associated with decreased medication side effects but not via medication changes.
Andrea R Collins, Simon Kung, Jacqueline T Ho, Jessica A Wright, Kristina C Dammen, Emily K Johnson, Maria I Lapid, Jonathan G Leung. J Psychiatr Res 2020
1
100



The utility of pharmacogenetic testing to support the treatment of bipolar disorder.
Marta Ielmini, Nicola Poloni, Ivano Caselli, Jordi Espadaler, Miquel Tuson, Alessandro Grecchi, Camilla Callegari. Pharmgenomics Pers Med 2018
22
50

Prospective use of CYP pharmacogenetics and medication analysis to facilitate improved therapy - a pilot study.
Ligia Chialda, Lee S Griffith, Antoinette Heinig, Andreas Pahl. Per Med 2008
3
50

Pharmacogenetics at Scale: An Analysis of the UK Biobank.
Gregory McInnes, Adam Lavertu, Katrin Sangkuhl, Teri E Klein, Michelle Whirl-Carrillo, Russ B Altman. Clin Pharmacol Ther 2021
17
50

Use of Pharmacogenetic Drugs by the Dutch Population.
Mohammad A Alshabeeb, Vera H M Deneer, Amjad Khan, Folkert W Asselbergs. Front Genet 2019
10
50

Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult Clinic.
Meghan J Arwood, Eric A Dietrich, Benjamin Q Duong, D Max Smith, Kelsey Cook, Amanda Elchynski, Eric I Rosenberg, Katherine N Huber, Ying L Nagoshi, Ashleigh Wright,[...]. J Clin Med 2020
13
50

Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice.
Kathryn J Ruddy, Stephen D Desantis, Rebecca S Gelman, Alan H B Wu, Rinaa S Punglia, Erica L Mayer, Sara M Tolaney, Eric P Winer, Ann H Partridge, Harold J Burstein. Breast Cancer Res Treat 2013
18
50

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.
J A Luzum, R E Pakyz, A R Elsey, C E Haidar, J F Peterson, M Whirl-Carrillo, S K Handelman, K Palmer, J M Pulley, M Beller,[...]. Clin Pharmacol Ther 2017
81
50

Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece.
Yuan Mai, Christina Mitropoulou, Xanthi E Papadopoulou, Athanassios Vozikis, David N Cooper, Ron H van Schaik, George P Patrinos. Per Med 2014
26
50

Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.
W S Bush, D R Crosslin, A Owusu-Obeng, J Wallace, B Almoguera, M A Basford, S J Bielinski, D S Carrell, J J Connolly, D Crawford,[...]. Clin Pharmacol Ther 2016
96
50

Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece.
Alexandra Alexopoulou, Spyros P Dourakis, Demosthenes Mantzoukis, Thomas Pitsariotis, Anna Kandyli, Melanie Deutsch, Athanasios J Archimandritis. Eur J Intern Med 2008
69
50

The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study.
John Papastergiou, Peter Tolios, Wilson Li, Jane Li. J Am Pharm Assoc (2003) 2017
18
50

Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study.
Peter Hanlon, Barbara I Nicholl, Bhautesh Dinesh Jani, Ross McQueenie, Duncan Lee, Katie I Gallacher, Frances S Mair. BMJ Open 2018
29
50

Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
Yuan Ji, Jennifer M Skierka, Joseph H Blommel, Brenda E Moore, Douglas L VanCuyk, Jamie K Bruflat, Lisa M Peterson, Tamra L Veldhuizen, Numrah Fadra, Sandra E Peterson,[...]. J Mol Diagn 2016
93
50

P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes.
Thomas J Povsic, E Magnus Ohman, Matthew T Roe, Jennifer White, Frank W Rockhold, Gilles Montalescot, Jan H Cornel, Jose C Nicolau, P Gabriel Steg, Stefan James,[...]. JAMA Cardiol 2019
6
50

A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder.
Joel G Winner, Joseph M Carhart, C Anthony Altar, Josiah D Allen, Bryan M Dechairo. Discov Med 2013
110
50

The Integrating Pharmacogenetics in Clinical Care (I-PICC) Study: Protocol for a point-of-care randomized controlled trial of statin pharmacogenetics in primary care.
Jason L Vassy, Charles A Brunette, Nilla Majahalme, Sanjay Advani, Lauren MacMullen, Cynthia Hau, Andrew J Zimolzak, Stephen J Miller. Contemp Clin Trials 2018
5
50

Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
Chun-Yu Wei, Ming-Ta Michael Lee, Yuan-Tsong Chen. Hum Mol Genet 2012
51
50

An observational study of the impact of genetic testing for pain perception in the clinical management of chronic non-cancer pain.
Maneesh Sharma, Svetlana Kantorovich, Chee Lee, Natasha Anand, John Blanchard, Eric T Fung, Brian Meshkin, Ashley Brenton, Steven Richeimer. J Psychiatr Res 2017
7
50

Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands.
Anne J Leendertse, Antoine C G Egberts, Lennart J Stoker, Patricia M L A van den Bemt. Arch Intern Med 2008
443
50


Clinical Outcomes Following the Use of Archived Proviral HIV-1 DNA Genotype to Guide Antiretroviral Therapy Adjustment.
Kristen E Ellis, George T Nawas, Connie Chan, Lawrence York, Julia Fisher, Elizabeth Connick, Tirdad T Zangeneh. Open Forum Infect Dis 2019
2
50

Outlier and influence diagnostics for meta-analysis.
Wolfgang Viechtbauer, Mike W-L Cheung. Res Synth Methods 2010
490
50

Prospective CYP2C19 Genotyping to Guide Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Pragmatic Randomized Clinical Trial.
Sony Tuteja, Henry Glick, William Matthai, Irving Nachamkin, Ashwin Nathan, Karen Monono, Craig Carcuffe, Karen Maslowski, Gene Chang, Taisei Kobayashi,[...]. Circ Genom Precis Med 2020
16
50

Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study).
Robert S Epstein, Thomas P Moyer, Ronald E Aubert, Dennis J O Kane, Fang Xia, Robert R Verbrugge, Brian F Gage, J Russell Teagarden. J Am Coll Cardiol 2010
242
50

Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status.
E A G Joosten, L DeFuentes-Merillas, G H de Weert, T Sensky, C P F van der Staak, C A J de Jong. Psychother Psychosom 2008
574
50

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. BMJ 2009
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.